Haemonetics Announces Proposed Convertible Senior Notes Offering

BOSTON, May 21, 2024 /PRNewswire/ — Haemonetics Corporation (“Haemonetics”) (NYSE: HAE) today announced its intention to offer, subject to market and other conditions, $525,000,000 aggregate principal amount of Convertible Senior Notes due 2029 (the “notes”) in a private offering (the…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks